{"id":55191,"date":"2023-03-27T11:03:06","date_gmt":"2023-03-27T09:03:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/"},"modified":"2023-03-27T11:03:06","modified_gmt":"2023-03-27T09:03:06","slug":"the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/","title":{"rendered":"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5739926\/the-market-future-potential-molecular-point?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=4mv79l&amp;utm_campaign=1833841+-+The+Market+and+Future+Potential+for+Molecular+Point+of+Care+(mPOC)+to+2027&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;The Market and Future Potential for Molecular Point of Care (mPOC), 2023&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from a novel trend to a significant contributor to the market.\n<\/p>\n<p>\nThe instruments sold by Abbott, BioMerieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point-of-care testing and microbiology IVD.\n<\/p>\n<p>\nThe report provides market sizing, forecasting, trend mapping and competitive analysis for point-of-care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings.\n<\/p>\n<p>\nThe data in <em>The Market and Future Potential for Molecular Point of Care (POC), 2023 <\/em>includes information on systems and competitor analysis, as well as data on the size and growth of the market:\n<\/p>\n<ul>\n<li>\nWhat are the mPOC market opportunities beyond COVID-19?\n<\/li>\n<li>\nWhat are the current systems on the market? Who&#8217;s winning?\n<\/li>\n<li>\nWhat&#8217;s the size of the Molecular Point of Care Market: 2022-2027\n<\/li>\n<li>\nGeographic Breakout of the Molecular Point of Care Market, 2021 (N. America, Europe, APAC, RoW)\n<\/li>\n<li>\nSegment Breakout of Molecular Point of Care Market, 2022 (Respiratory vs. Other)\n<\/li>\n<li>\nRespiratory Segment Breakout, 2022 (Flu, RSV, Strep, Other)\n<\/li>\n<li>\nBreakout of mPOC Respiratory, 2022 (%; Flu, Strep, RSV, Other)\n<\/li>\n<li>\nNear Patient Molecular IVD Market: 2022-2027\n<\/li>\n<li>\nNear Patient Molecular Market Share by Vendor, 2022\n<\/li>\n<li>\nMolecular Point of Care Market Share by Vendor, 2022\n<\/li>\n<li>\nCompany Profiles\n<\/li>\n<\/ul>\n<p>\nMany trends are covered in the report, including the role of COVID-19 testing, menu expansion, disease statistics, the COVID-19 crisis, immunoassay competition and enhancement of those competitive POC systems, emerging markets, new journal studies about the efficacy of mPOC, and other trends.\n<\/p>\n<p>\n<strong>Companies covered in this report, in profiles and\/or product tables and market developments discussion include:<\/strong>\n<\/p>\n<ul>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nAidian Oy\n<\/li>\n<li>\nAkonni Biosystems\n<\/li>\n<li>\nAnitoa\n<\/li>\n<li>\nbinx health, inc.\n<\/li>\n<li>\nBiocartis NV\n<\/li>\n<li>\nBioGX\n<\/li>\n<li>\nbioMerieux SA\n<\/li>\n<li>\nCepheid\n<\/li>\n<li>\nCredo Bioscience\n<\/li>\n<li>\nCue Health\n<\/li>\n<li>\nCuretis NV\n<\/li>\n<li>\nCuriosity Diagnostics (Bio-Rad)\n<\/li>\n<li>\nDiaSorin S.p.A\n<\/li>\n<li>\nDomus Diagnostics\n<\/li>\n<li>\nFluxergy\n<\/li>\n<li>\nGenMark Diagnostics\n<\/li>\n<li>\nGenomadix\n<\/li>\n<li>\nGreiner Bio-One GmbH\n<\/li>\n<li>\nLEX Diagnostics\n<\/li>\n<li>\nMeridian Bioscience, Inc.\n<\/li>\n<li>\nMesa Biotech, Inc.\n<\/li>\n<li>\nMicroGEM\n<\/li>\n<li>\nMinute Molecular\n<\/li>\n<li>\nNanopath\n<\/li>\n<li>\nQIAGEN NV\n<\/li>\n<li>\nQuantuMDx Group\n<\/li>\n<li>\nQuidel Corporation\n<\/li>\n<li>\nRoche\n<\/li>\n<li>\nRover Diagnostics\n<\/li>\n<li>\nSekisui Diagnostics LLC\n<\/li>\n<li>\nT2 Biosystems\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered<\/strong>\n<\/p>\n<p>\n<strong>Chapter 1: Executive Summary<\/strong>\n<\/p>\n<ul>\n<li>\nMolecular Point of Care Market, 2022-2026 ($M)\n<\/li>\n<li>\nNear Patient Molecular Systems Market: 2022-2027 ($M)\n<\/li>\n<li>\nWhere is Molecular Point of Care in 2023?\n<\/li>\n<li>\nMolecular Point of Care Market, 2022-2027 ($M)\n<\/li>\n<li>\nMolecular Point of Care Market Analysis\n<\/li>\n<li>\nMolecular Point of Care Market, 2022-2027 (%)\n<\/li>\n<li>\nMpoc Market by Disease Indication, 2022 (%; Respiratory, Other)\n<\/li>\n<li>\nMarket Observations\n<\/li>\n<li>\n&#8220;Near-Patient&#8221; Molecular Systems Market\n<\/li>\n<li>\nMpoc and Near-Patient Market, 2022-2027\n<\/li>\n<li>\nNear Patient Molecular Systems Market, 2022-2027 ($M and %)\n<\/li>\n<li>\nCurrent Trends\n<\/li>\n<li>\nMolecular Point-Of-Care Diagnostics Defined\n<\/li>\n<li>\nUsage of Molecular Point of Care\n<\/li>\n<li>\nLeading Mpoc Platforms\n<\/li>\n<li>\nMolecular Poc Diagnostic Platforms and Technologies\n<\/li>\n<li>\nTrends\n<\/li>\n<li>\nScope and Methodology\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 2: Molecular Point-Of-Care Market Development and Trends<\/strong>\n<\/p>\n<ul>\n<li>\nCovid-19 and Molecular Poc\n<\/li>\n<li>\nMolecular Poc Covid-19 Emergency Authorizations\n<\/li>\n<li>\nCdc Initial Response, Long Term Situation\n<\/li>\n<li>\nCovid-19&#8217;s Unique Challenge\n<\/li>\n<li>\nBarda Directs Funding to Mpoc\n<\/li>\n<li>\nRecent Regulatory Developments\n<\/li>\n<li>\nConsortia, Funding, Prizes\n<\/li>\n<li>\nDeals\n<\/li>\n<li>\nDeals in Molecular Point of Care, April 2019-January 2023\n<\/li>\n<li>\nAdvantages and Disadvantages of Molecular Point of Care\n<\/li>\n<li>\nDisadvantages of Molecular Point of Care, by Setting (Physician Office Laboratory (Pol) \/ Other Outpatient Settings, Developing and Low-Resource Areas, and Hospital Poc)\n<\/li>\n<li>\nJustification: the Sensitivity\/Specificity Argument\n<\/li>\n<li>\nNew Systems and Menu Expansion\n<\/li>\n<li>\nMesa Biotech Strep a Approval\n<\/li>\n<li>\nCombination Tests Enter Market: Sars-Cov-2, Flu A, Flu B, and Rsv\n<\/li>\n<li>\nSti Continues to Be a Growth Area\n<\/li>\n<li>\nDeals, Investment in Mpoc Systems\n<\/li>\n<li>\nThermo Acquires Mesa Biotech\n<\/li>\n<li>\nEu Researchers Awarded \u20ac3M to Develop Poc Molecular Tests\n<\/li>\n<li>\nScope Fluidics Ast System Sees Investment\n<\/li>\n<li>\nChina as a Poc Market\n<\/li>\n<li>\nCommon Tests and Analytes in Poc Diagnostics\n<\/li>\n<li>\nComponent Technologies of Molecular Point-Of-Care Diagnostics\n<\/li>\n<li>\nMicrofluidics\n<\/li>\n<li>\nQpcr\n<\/li>\n<li>\nMicroarrays\n<\/li>\n<li>\nIsothermal Amplification\n<\/li>\n<li>\nTest Automation\n<\/li>\n<li>\nPrimers and Probes\n<\/li>\n<li>\nDetection\n<\/li>\n<li>\nNext-Generation Sequencing\n<\/li>\n<li>\nMolecular Diagnostics\n<\/li>\n<li>\nReal-Time Pcr (Qpcr)\n<\/li>\n<li>\nIsothermal Amplification Methods\n<\/li>\n<li>\nLine Probe Assays\n<\/li>\n<li>\nNext-Generation Sequencing\n<\/li>\n<li>\nApplications and Potential Applications for Molecular Point-Of-Care\n<\/li>\n<li>\nMajor Testing Applications for Molecular Poc Diagnostics\n<\/li>\n<li>\nInfluenza\n<\/li>\n<li>\nReclassification of Ridts\n<\/li>\n<li>\nHospital-Acquired Infections (Hais)\n<\/li>\n<li>\nStrep A\n<\/li>\n<li>\nRespiratory Syncytial Virus (Rsv)\n<\/li>\n<li>\nEmerging Applications\n<\/li>\n<li>\nZika\n<\/li>\n<li>\nOther Respiratory Infections\n<\/li>\n<li>\nGroup B Streptococcus\n<\/li>\n<li>\nHuman Papillomavirus\n<\/li>\n<li>\nHerpes Simplex Virus\n<\/li>\n<li>\nVaginitis\n<\/li>\n<li>\nTuberculosis\n<\/li>\n<li>\nMalaria\n<\/li>\n<li>\nOther Tropical and Neglected Diseases\n<\/li>\n<li>\nCancer\n<\/li>\n<li>\nEuropean Device Regulations Nearing\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 3: Market Analysis<\/strong>\n<\/p>\n<ul>\n<li>\nMolecular Point of Care Market Analysis\n<\/li>\n<li>\nMolecular Point of Care Market, 2022-2027 ($M, %)\n<\/li>\n<li>\nMolecular Point of Care Market, 2022-2026 ($M)\n<\/li>\n<li>\nMolecular Point of Care Market Share, by Vendor (Abbott, Biomerieux, Cepheid, Cue Health, Roche, Other), 2022 ($M, %)\n<\/li>\n<li>\nMolecular Point of Care Market Share, by Vendor (Abbott, Biomerieux, Cepheid, Cue Health, Roche, Other), 2022 (%)\n<\/li>\n<li>\nGeographic Breakout of the Molecular Point of Care Market, 2022\n<\/li>\n<li>\nSegment Breakout of Molecular Point of Care Market, 2022 (Covid-Respiratory Vs. Other)\n<\/li>\n<li>\nBreakout of Molecular Point of Care Market (Respiratory, Other), 2022 (%)\n<\/li>\n<li>\n&#8220;Near Patient Molecular&#8221; Market\n<\/li>\n<li>\nNear Patient Molecular Systems Market, 2022-2027\n<\/li>\n<li>\nMarket Share Near Patient\n<\/li>\n<li>\nMarket Share, Near Patient Molecular Testing, (Abbott, Biomerieux, Cepheid, Cue Health, Roche, Other), 2022\n<\/li>\n<\/ul>\n<p>\n<strong>Chapter 4: Company Profiles<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5739926\/the-market-future-potential-molecular-point?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=4mv79l&amp;utm_campaign=1833841+-+The+Market+and+Future+Potential+for+Molecular+Point+of+Care+(mPOC)+to+2027&amp;utm_exec=chdo54prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/bt7reu<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;&#x74;o&#58;&#x70;&#x72;&#x65;s&#115;&#x40;&#x72;&#x65;s&#101;&#x61;&#x72;&#x63;h&#97;&#x6e;&#x64;&#x6d;a&#114;&#x6b;&#x65;&#x74;s&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pre&#115;&#115;&#64;&#114;&#x65;&#x73;&#x65;&#x61;&#x72;&#x63;&#x68;and&#109;&#97;&#114;&#107;&#101;&#x74;&#x73;&#x2e;&#x63;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;The Market and Future Potential for Molecular Point of Care (mPOC), 2023&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from a novel trend to a significant contributor to the market. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55191","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;The Market and Future Potential for Molecular Point of Care (mPOC), 2023&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from a novel trend to a significant contributor to the market. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-27T09:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-03-27T09:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/\"},\"wordCount\":925,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005316\\\/en\\\/1747729\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/\",\"name\":\"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005316\\\/en\\\/1747729\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-03-27T09:03:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005316\\\/en\\\/1747729\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230327005316\\\/en\\\/1747729\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;The Market and Future Potential for Molecular Point of Care (mPOC), 2023&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from a novel trend to a significant contributor to the market. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-27T09:03:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 &#8211; ResearchAndMarkets.com","datePublished":"2023-03-27T09:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/"},"wordCount":925,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/","name":"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg","datePublished":"2023-03-27T09:03:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230327005316\/en\/1747729\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-market-and-future-potential-for-molecular-point-of-care-mpoc-to-2027-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The Market and Future Potential for Molecular Point of Care (mPOC) to 2027 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55191"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55191\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}